De J. Rangel-Trevino

Monterrey, NLE, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Establishment of epidemiological cutoff values against Fonsecaea monophora, an agent of chromoblastomycosis and cerebral phaeohyphomycosis.

Establishment of epidemiological cutoff values against Fonsecaea monophora, an agent of chromoblastomycosis and cerebral phaeohyphomycosis.

Journal: Journal of clinical microbiology

Published: June 25, 2026

Shift of antibiotic resistance after the COVID-19 pandemic: results from the INVIFAR Network.

Shift of antibiotic resistance after the COVID-19 pandemic: results from the INVIFAR Network.

Journal: JAC-antimicrobial resistance

Published: February 03, 2026

Breakthrough Tracheobronchial Aspergillosis Caused by Aspergillus calidoustus and Aspergillus niger in a Lung Transplant Recipient Despite Combined Antifungal Prophylaxis.

Breakthrough Tracheobronchial Aspergillosis Caused by Aspergillus calidoustus and Aspergillus niger in a Lung Transplant Recipient Despite Combined Antifungal Prophylaxis.

Journal: Case reports in pulmonology

Published: January 14, 2026

Cytokine Profile and Oxidative Patterns in Murine Models of Disseminated Infection by Mucorales Species.

Cytokine Profile and Oxidative Patterns in Murine Models of Disseminated Infection by Mucorales Species.

Journal: Pathogens (Basel, Switzerland)

Published: September 10, 2025

An Unusual Case of Chronic Delimited Rhinosinusal Mucormycosis With Secondary Cutaneous Involvement in a Patient With Ataxia-Telangiectasia Syndrome.

An Unusual Case of Chronic Delimited Rhinosinusal Mucormycosis With Secondary Cutaneous Involvement in a Patient With Ataxia-Telangiectasia Syndrome.

Journal: Cureus

Published: July 17, 2025

Tannic acid exhibits therapeutic effects against azole-resistant invasive candidiasis and enhances the antifungal activity of fluconazole.

Tannic acid exhibits therapeutic effects against azole-resistant invasive candidiasis and enhances the antifungal activity of fluconazole.

Journal: Microbial pathogenesis

Published: May 24, 2025

Novel antifungal compounds against Fusarium spp: A systematic review.

Novel antifungal compounds against Fusarium spp: A systematic review.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: April 29, 2025

Nanomaterials and Candida auris: A Systematic Review of Emerging Strategies.

Nanomaterials and Candida auris: A Systematic Review of Emerging Strategies.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: December 27, 2024

Iatrogenic infection by atypical mycobacteria: a case report of M. phlei infection in an immunocompetent patient simulating breast malignancy.

Iatrogenic infection by atypical mycobacteria: a case report of M. phlei infection in an immunocompetent patient simulating breast malignancy.

Journal: Journal of infection in developing countries

Published: December 09, 2024

Sertraline exhibits in vivo antifungal activity against Candida auris and enhances the effect of voriconazole in combination.

Sertraline exhibits in vivo antifungal activity against Candida auris and enhances the effect of voriconazole in combination.

Journal: Microbial pathogenesis

Published: June 25, 2024

Clavispora lusitaniae: From a saprophytic yeast to an emergent pathogen.

Clavispora lusitaniae: From a saprophytic yeast to an emergent pathogen.

Journal: Fungal biology

Published: July 25, 2023

Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review.

Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review.

Journal: Journal of fungi (Basel, Switzerland)

Published: September 15, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026